Skip to main content
Clinical Trials/NCT03467503
NCT03467503CompletedNot Applicable

Healthy Diet for Healthy Moms and Babies

University of Nevada, Las Vegas2 sites in 1 country34 target enrollmentStarted: May 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
34
Locations
2
Primary Endpoint
Gestational weight gain

Study Overview

Brief Summary

The purpose of this clinical study is to collect baseline information on dietary habits and metabolic risk factors, and to examine the effects of a dietary intervention focusing on fiber and antioxidant rich berries on the development of gestational diabetes, maternal glucose and lipid control and inflammation in obese pregnant women at risk of developing diabetes. With the ongoing epidemic of obesity, the prevalence of gestational diabetes is significantly increasing and the goal of this research is to identify optimal dietary strategies that can reverse this condition or control the rise in blood glucose among those with already developed diabetes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Care Provider)

Eligibility Criteria

Ages
19 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • BMI > or = 30, <20 weeks gestation and singleton pregnancy with the following options: previous history of gestational diabetes and/or family history of diabetes

Exclusion Criteria

  • • Twin or multiple pregnancy
  • Chronic pre-pregnancy conditions (CHD, cancer, diabetes)
  • Gastrointestinal conditions
  • Allergic to berries and fiber
  • Vegetarian food habits or special diets
  • Not proficient in English and/or unable to provide consent

Outcomes

Primary Outcomes

Gestational weight gain

Time Frame: 20 weeks

Maternal weight gain in lbs

Maternal inflammation

Time Frame: 20 weeks

C-reactive protein as a stable biomarker of inflammation

Gestational glycemia

Time Frame: 20 weeks

Maternal blood glucose and HbA1c as measures of glycemia

Maternal serum lipids

Time Frame: 20 weeks

Conventional total, LDL-cholesterol and their particle size to describe lipid profiles

Secondary Outcomes

  • Maternal dietary intakes(20 weeks)
  • Maternal biomarkers of atherosclerosis(20 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Arpita Basu

Associate Professor

University of Nevada, Las Vegas

Study Sites (2)

Loading locations...

Similar Trials

Healthy Diet for Healthy Moms and Babies | Clinical Trial